AlphaQuest’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-8,451
Closed -$135K 407
2025
Q4
$135K Sell
8,451
-12,169
-59% -$181K 0.01% 1619
2025
Q3
$255K Buy
20,620
+4,549
+28% +$53.3K 0.02% 1262
2025
Q2
$185K Buy
16,071
+13,412
+504% +$159K 0.02% 1176
2025
Q1
$39.9K Buy
2,659
+2,658
+265,800% +$44.5K ﹤0.01% 1572
2024
Q4
$17 Sell
1
-9,652
-100% -$186K ﹤0.01% 1661
2024
Q3
$179K Sell
9,653
-6,531
-40% -$131K 0.02% 1112
2024
Q2
$328K Sell
16,184
-8,864
-35% -$157K 0.04% 607
2024
Q1
$428K Buy
+25,048
New +$394K 0.07% 411

Other funds holding CLB

AlphaQuest's CLB Position: Q1 2026 in Review

AlphaQuest sold out of Core Laboratories (CLB) in Q1 2026, closing a stake of 8,451 shares — an estimated $135K sold.

AlphaQuest first reported a position in CLB in Q1 2024 and held it in 8 quarters. The position peaked at $428K in Q1 2024. 190 funds tracked by Wall St. Rank hold CLB as of Q1 2026.

  • AlphaQuest reported no remaining Core Laboratories position as of Q1 2026 after selling out during the quarter.
  • AlphaQuest sold 8,451 Core Laboratories shares in Q1 2026, an estimated $135K.
  • AlphaQuest first reported a position in Core Laboratories in Q1 2024 and held it in 8 quarters.
  • AlphaQuest's Core Laboratories position peaked at $428K in Q1 2024.
  • 190 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.